Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer Unit.

Otsuki A, Otsuki T, Tokunaga H, Niikura H, Nagase S, Sugiyama T, Toyoshima M, Utsunomiya H, Yokoyama Y, Mizunuma H, Sato N, Terada Y, Shoji T, Sugiyama T, Nakahara K, Ohta T, Yamada H, Tase T, Nishiyama H, Fujimori K, Takano T, Takahashi F, Watanabe Y, Yaegashi N.

Int J Clin Oncol. 2015 Jun;20(3):574-8. doi: 10.1007/s10147-014-0732-0. Epub 2014 Jul 18.

PMID:
25030547
2.

Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit.

Otsuki A, Watanabe Y, Nomura H, Futagami M, Yokoyama Y, Shibata K, Kamoi S, Arakawa A, Nishiyama H, Katsuta T, Kudaka W, Shimada M, Sato N, Kotera K, Katabuchi H, Yaegashi N.

Int J Gynecol Cancer. 2015 Jan;25(1):92-7. doi: 10.1097/IGC.0000000000000302.

PMID:
25347097
3.

Clinical outcomes of uterine carcinosarcoma: results of 94 patients.

Gokce ZK, Turan T, Karalok A, Tasci T, Ureyen I, Ozkaya E, Kose MF, Tulunay G.

Int J Gynecol Cancer. 2015 Feb;25(2):279-87. doi: 10.1097/IGC.0000000000000347.

PMID:
25611900
4.
5.

The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.

Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL.

Int J Gynecol Cancer. 2016 Jan;26(1):141-8. doi: 10.1097/IGC.0000000000000561.

PMID:
26509850
6.

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.

Cantrell LA, Havrilesky L, Moore DT, O'Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN, Wallace AH, Rose P, Gehrig PA.

Gynecol Oncol. 2012 Oct;127(1):22-6. doi: 10.1016/j.ygyno.2012.06.020. Epub 2012 Jun 20.

PMID:
22727985
7.

Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.

Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS.

Gynecol Oncol. 2001 Oct;83(1):89-94.

PMID:
11585418
8.

Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study.

Takano T, Otsuki T, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, Niikura H, Ito K, Yaegashi N, Yamada H, Tase T, Kagabu M, Shoji T, Sugiyama T, Sato N, Fujimoto T, Terada Y, Nakahara K, Kurachi H, Yokoyama Y, Mizunuma H, Soeda S, Nishiyama H, Matsumoto T, Sato S, Shimada M, Kigawa J.

Int J Clin Oncol. 2014 Dec;19(6):1052-8. doi: 10.1007/s10147-013-0658-y. Epub 2014 Jan 7.

PMID:
24395448
9.

Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.

Makker V, Kravetz SJ, Gallagher J, Orodel OP, Zhou Q, Iasonos A, DeLair D, Aghajanian C, Hensley ML.

Int J Gynecol Cancer. 2013 Nov;23(9):1635-41. doi: 10.1097/IGC.0000000000000001.

PMID:
24172099
10.

Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.

Rauh-Hain JA, Starbuck KD, Meyer LA, Clemmer J, Schorge JO, Lu KH, Del Carmen MG.

Gynecol Oncol. 2015 Oct;139(1):84-9. doi: 10.1016/j.ygyno.2015.08.014. Epub 2015 Aug 22.

PMID:
26307402
11.

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).

Cha J, Kim YS, Park W, Kim HJ, Kim JY, Kim JH, Kim J, Yoon WS, Kim JW, Kim YB.

J Gynecol Oncol. 2016 Nov;27(6):e58. doi: 10.3802/jgo.2016.27.e58. Epub 2016 Jul 11.

12.

Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.

Garg G, Yee C, Schwartz K, Mutch DG, Morris RT, Powell MA.

Gynecol Oncol. 2014 May;133(2):242-9. doi: 10.1016/j.ygyno.2014.02.021. Epub 2014 Feb 19.

13.

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.

Makker V, Abu-Rustum NR, Alektiar KM, Aghajanian CA, Zhou Q, Iasonos A, Hensley ML.

Gynecol Oncol. 2008 Nov;111(2):249-54. doi: 10.1016/j.ygyno.2008.06.035. Epub 2008 Aug 27.

14.

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Galaal K, Godfrey K, Naik R, Kucukmetin A, Bryant A.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006812. doi: 10.1002/14651858.CD006812.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006812.

15.

Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.

Leath CA 3rd, Numnum TM, Kendrick JE 4th, Frederick PJ, Rocconi RP, Conner MG, Straughn JM Jr.

Int J Gynecol Cancer. 2009 Jul;19(5):888-91. doi: 10.1111/IGC.0b013e3181a831fb.

PMID:
19574779
16.

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Galaal K, van der Heijden E, Godfrey K, Naik R, Kucukmetin A, Bryant A, Das N, Lopes AD.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD006812. doi: 10.1002/14651858.CD006812.pub3. Review.

PMID:
23450572
17.

Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.

Dandamudi RK, Aslam S, Walji N, El-Modir A, Fernando I.

Anticancer Res. 2015 Sep;35(9):4841-7.

PMID:
26254376
18.

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.

Sutton G, Kauderer J, Carson LF, Lentz SS, Whitney CW, Gallion H; Gynecologic Oncology Group.

Gynecol Oncol. 2005 Mar;96(3):630-4.

PMID:
15721404
19.

The retrospective analysis of patients with uterine sarcomas: A single-center experience.

Terek MC, Akman L, Hursitoglu BS, Sanli UA, Ozsaran Z, Tekindal MA, Dikmen Y, Zekioglu O, Ozsaran AA.

J Cancer Res Ther. 2016 Jan-Mar;12(1):309-13. doi: 10.4103/0973-1482.148698.

20.

Carboplatin-Paclitaxel versus Cisplatin-Ifosfamide in the treatment of uterine carcinosarcoma: a retrospective cohort study.

Lorusso D, Martinelli F, Mancini M, Sarno I, Ditto A, Raspagliesi F.

Int J Gynecol Cancer. 2014 Sep;24(7):1256-61. doi: 10.1097/IGC.0000000000000215.

PMID:
25078338

Supplemental Content

Support Center